coronavirus
EQT warns of "longer" fundraising for flagship vehicle
GP states it is currently focusing on developing existing portfolio companies until market recovery
Half of GPs prepared to hire based on video interviews - survey
Survey conducted by PER shows that 52% of participants could make offers from video interviews
UK government extends lifeline to PE assets, but obstacles remain
Clarification for CBILS is deemed helpful, but concerns linger for the Coronavirus Large Business Interruption Loan Scheme (CLBILS)
Verdane invests in Conscriptor and Max Manus
GP will merge the two companies to form a new healthcare technology group in Scandinavia
Market braces for 12.6% drop in valuations by Q2 – report
NAVs expected to drop for Q1, with a steeper mark-down for Q2 as the crisis take its toll
Q&A: SHS's Alilovic on healthtech investing
New managing partner Sascha Alilovic talks to Unquote about the healthtech investor's plans
Maven invests £2.5m in Precursive
All-equity investment will go towards a growth strategy in both the UK and the US
Unquote Private Equity Podcast: Fund financing in a fix
The Unquote team looks at how PE managers are turning to fund financing in a bid to shore up their portfolios
CVC delays £300m Six Nations investment – report
In February 2020, the Financial Times reported the firm was expected to acquire a 14% stake for ТЃ300m
KKR expects lower valuations for its portfolios due to Covid-19
GP forecasts that emergency restrictions will challenge its ability to market new funds and strategies
Coronavirus: European LPs contemplate course corrections
LPs are not unanimous in their opinion of how the current pandemic will reshape ways of thinking
EC launches €300m platform Escalar
In its pilot phase, Escalar will provide up to тЌ300m, backed by the European Fund for Strategic Investments
Wellington Partners makes seed investment in Sirs Therapeutics
Life science and technology investor Wellington is the majority owner of the early-stage company
European consumer M&A presents opportunities in Covid-19 chaos
Europe's consumer sector offers pockets of opportunity as the coronavirus pandemic wreaks havoc on M&A
GPs turn to preferred equity in hunt for emergency liquidity
GPs seek to raise pots of capital fast to insulate their portfolio companies from the economic fallout of Covid-19
Secondaries players hold fire despite copious dry powder
Market is likely to pause until Q2 2020 valuations are released, potentially leading to a flurry in Q4
VCs ramp up coronavirus mitigation efforts
Partners from Balderton, General Atlantic, Anthemis Partners, TCV and Speedinvest dicuss the crisis
Silverfern holds first close for SGO Fund III
GP expects a final close in 2020 and sees market opportunities in spite of the coronavirus pandemic
Italian fundraising processes disrupted by Covid-19 crisis
A round-up of the processes affected, as well as those still pushing through despite the pandemic
Q&A: Cambridge Associates' Featherby on PE's time to shine
Very few managers will have net benefited from this crisis, says Featherby, but PE could still showcase its ability to outperform
How private equity is helping fight the Covid-19 outbreak
A round-up of initiatives by GPs across Europe т and their portfolio companies т to help their communities
Eurazeo to set up €10m Covid-19 solidarity fund
GP wants to suspend its 2019 dividend, and senior execs will contribute 10% of their bonuses to the fund
EQT enters exclusive negotiations to acquire Schülke
Sale process saw EBITDA adjustments due to the hygiene product company's increased revenues
BVCA proposes £500m early-stage funding facility
Submission proposes a bridge funding facility in the form of a convertible loan of up to ТЃ5m per company